Introduction
Measles, mumps, rubella, and varicella remain potential risks for transmission in healthcare settings. A healthcare worker (HCW) who lacks immunity is at high risk for contracting the disease, for complications, and for transmitting the infection to susceptible patients (1) (2) (3) (4) (5) (6) (7) (8) .
In Jordan, no data exist on the susceptibility rates among HCWs for measles, mumps, rubella, or varicella. Furthermore, to our knowledge, vaccination programs for these infections are not implemented in most Jordanian hospitals. Here, we aim first to determine the seroprevalence of these infections in 2 groups of HCWs: 1 group of physicians and 1 group of nurses working in a large university hospital in Jordan. Second, we aim to compare the history of varicella with varicella antibodies among the study participants. Our data would help in estimating the risks posed to HCWs by these infections and in developing vaccination policies in our area.
Methods and materials
The study was conducted at the Jordan University Hospital (Amman, Jordan), which is a large teaching and tertiary hospital with 540 bed capacity. It serves both children and adults with a working staff of 542 physicians and 775 nurses. The hospital has no vaccination program for HCWs for any of the tested infections.
The study was approved by the hospital's institutional review board. We aimed to select 1 group of physicians and 1 group of nurses. A sample size of around 250 participants in each group of physicians and nurses was recommended, assuming seroprevalence for the tested infections of 80%, significance level of 0.05, and accuracy of 5 percentage points. Systematic sampling was used to select participants; a list for staff names for each group was generated and sorted according to alphabetical order. Selection was conducted by including every second name in the physician list and every third name in the nurse list.
In case of refusal or unavailability, the next name in the list was selected. Investigators interviewed the participants and collected blood samples.
Collected sera were frozen and later tested using a commercial enzyme-linked immunosorbent assay. Blood was tested for IgG antibodies to measles, mumps, varicella zoster virus (IBL International, Germany), and rubella (Biorad, France) according to the manufacturer's instructions. Equivocal results were considered negative (9) . Participants were informed about their results and those who had seronegative results were advised to take the appropriate vaccines.
Seroprevalence was calculated for each group of physicians and nurses and for the combined 2 groups. For analysis, we used the chi-square test for proportion data and the Mann-Whitney U test for nonparametric data. Results were considered statistically significant if the 2-tailed P-value was <0.05. Statistical analysis was done with SPSS 16. Seroprevalence and the predictive value of history of varicella infection were calculated as previously described (8, 10) .
Results
The study was performed between March 2011 and March 2012. Sixty-two HCWs (27 physicians and 35 nurses) refused to participate and 5 HCWs were found to have resigned. We excluded 7 blood samples because names on the blood samples were missing. Out of 1972 tests, 156 (8%) gave an equivocal result. Equivocal results accounted for 59.8% of the negative samples.
Characteristics of study participants
The total number of participants was 493 (252 physicians and 241 nurses). All participants were Jordanian. Overall mean age was 30 years (SD: ±7.3; range: 22-67). The physician group had significantly more males and younger participants than the nurse group (Table 1) .
Seroprevalence and associated factors
The total number of participants with antibodies to measles was 371 (75.3%), mumps 450 (91.3%), rubella 435 (88.2%), and varicella 455 (92.3%) ( Table 1 ). Immunity to tested diseases was similar between the physician and nurse groups except for mumps, where significantly more nurses were immune (P = 0.025) ( Table 1) . A total of 5 participants were born before 1957 (4 male physicians and 1 male nurse), and all had protective antibodies to all tested diseases. Of all participants, 184 (97 physicians, 87 nurses; 37%) had no immunity to at least 1 of the 3 infectionsmeasles, mumps, or rubella -for which a single combined vaccine formulation is available, and 202 (105 physicians, 97 nurses) participants (40%) had no immunity to at least 1 of the 4 tested infections.
Testing for associations between immunity and age or sex showed that, in the physician group, immunity to measles significantly increased with age, whereas in the nurse group, immunity to both measles and mumps significantly increased with age and females were more likely to be immune to measles (Table 2 ). In addition, after separating the participants according to birthdate before or after the year 1982 (the year in which the measles vaccine was introduced into the national vaccination program), (Table 6 ). When participants with an unknown history of varicella were included in the group with a negative history of varicella infection, the sensitivity and specificity became 67.2% and 60%, respectively, for physicians and 49.3% and 66.7% for nurses (Table 6 ).
Discussion
Here, the seroprevalence for measles was 75.4%, 75.1%, and 75.3% for the physicians, nurses, and the combined groups, respectively; mumps, 88.5%, 94.2%, and 91.3%; rubella, 89.3%, 87.1%, and 88.2%; and varicella, 92.1%, 92.5%, and 92.3%. Available seroprevalence studies from neighboring areas are scarce and show a range from 87% to 91% for measles (11-13), 92%-93% for mumps (12,13), 90%-98% for rubella (11) (12) (13) , and 71%-98.5% for varicella (11) (12) (13) (14) (15) (16) (17) (18) . Therefore, our results, except for measles, are within the regional range. However, such results in healthcare workers might be unsatisfactory, since these Mann-Whitney U test. Sensitivity (neg + u): sensitivity when people with unknown histories were added to those with a negative history. Specificity (neg + u): specificity when people with unknown histories were added to those with a negative history.
infections are highly transmissible and require very high population-level immunity (19) . There was no significant difference in immunity between the physician and nurse groups except for mumps, where more nurses (94.2%) than physicians (88.5%) (P = 0.025) were immune, which could be due to the older age of participating nurses. The finding that immunity to measles and mumps increases with age has been previously reported and was attributed to the possible low uptake of vaccine and the low exposure among the young age group (7, (20) (21) (22) (23) . This explanation is further supported herein by finding significantly more immunity in participants born before the introduction of the measles vaccine in 1982 than in those born later. In addition, our finding that all 5 participants born before 1957 were immune to the tested infections is consistent with the Centers for Disease Control and Prevention definition, which states that persons born before 1957 are considered to have acceptable presumptive evidence of immunity to measles, rubella, and mumps (9) .
In this study, the overall immunity rate to rubella was 88% (Table 1) and that for women of childbearing age was 89% (Table 3) . These results are in accordance with 2 earlier community studies in Jordan: the first found that the overall immunity to rubella was 81% for women aged 15-35 years (24) . The second found that the immunity for women from 15 to 49 years was 91%, but that for women aged 15-19 years, it dropped to 83% (25) . These findings are significant because the incidence of congenital rubella in a given population depends on the number of susceptible individuals, the circulation of virus in the community, and the use of the rubella vaccine (26) .
Our results also indicate that the PPV of the recalled history of varicella (95% for the overall participants) is not high enough to safely consider those with a positive varicella history to be immune, since 14 of the 280 participants (5%) with a positive history of varicella were found to be seronegative. Moreover, the NPV of the recalled history of varicella (13.5% for all participants) was poor, meaning that a negative history of varicella was able to correctly identify only a few susceptible participants. For all participants, a negative or unknown history against varicella was able to detect 63% of seronegative participants, whereas 37% of seronegative participants were not detected by history. Therefore, to avoid missing seronegative HCWs, we recommend that all HCWs in our institution be tested for immunity against varicella and those who test seronegative should receive the varicella vaccine.
Our study is mainly limited by being conducted at a single healthcare facility. However, since our hospital serves a wide range of Jordan's population and the employees are all Jordanian, we think that our results are applicable to and representative of HCWs throughout the country.
In conclusion, among our population of HCWs, rates of immunity to measles are low, while those to mumps, rubella, and varicella are relatively high but still unsatisfactory. This highlights the need to establish policies to ensure protective immunity through testing, followed by vaccination of seronegative staff. Recall history of varicella poorly detected immunity to varicella, suggesting that the best approach to ensure acceptable levels of immunity to varicella is to test all HCWs for this virus and vaccinate those who are seronegative.
